Andrew C. Nyborg

1.8k total citations
34 papers, 1.4k citations indexed

About

Andrew C. Nyborg is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Andrew C. Nyborg has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Physiology and 8 papers in Immunology. Recurrent topics in Andrew C. Nyborg's work include Alzheimer's disease research and treatments (9 papers), Metalloenzymes and iron-sulfur proteins (8 papers) and Electrocatalysts for Energy Conversion (5 papers). Andrew C. Nyborg is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Metalloenzymes and iron-sulfur proteins (8 papers) and Electrocatalysts for Energy Conversion (5 papers). Andrew C. Nyborg collaborates with scholars based in United States, Japan and Sweden. Andrew C. Nyborg's co-authors include Todd E. Golde, Thomas B. Ladd, Chris McLendon, Pritam Das, Linda H. Younkin, Mikio Shoji, Steven G. Younkin, Takeshi Kawarabayashi, Suzanne E. Wahrle and Gerald D. Watt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Andrew C. Nyborg

34 papers receiving 1.3k citations

Peers

Andrew C. Nyborg
Nunziata Maio United States
Pamela Mertz United States
Robert Schoenleber United States
Jianhe Peng United Kingdom
A. Michel France
Nunziata Maio United States
Andrew C. Nyborg
Citations per year, relative to Andrew C. Nyborg Andrew C. Nyborg (= 1×) peers Nunziata Maio

Countries citing papers authored by Andrew C. Nyborg

Since Specialization
Citations

This map shows the geographic impact of Andrew C. Nyborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew C. Nyborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew C. Nyborg more than expected).

Fields of papers citing papers by Andrew C. Nyborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew C. Nyborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew C. Nyborg. The network helps show where Andrew C. Nyborg may publish in the future.

Co-authorship network of co-authors of Andrew C. Nyborg

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew C. Nyborg. A scholar is included among the top collaborators of Andrew C. Nyborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew C. Nyborg. Andrew C. Nyborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhongbo, Limei Shen, Alice Ma, et al.. (2023). Pegloticase co-administered with high MW polyethylene glycol effectively reduces PEG-immunogenicity and restores prolonged circulation in mouse. Acta Biomaterialia. 170. 250–259. 12 indexed citations
2.
Feldwisch, Joachim, Lindvi Gudmundsdotter, Elin Gunneriusson, et al.. (2023). Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis. mAbs. 15(1). 2209920–2209920. 35 indexed citations
3.
McSweeney, Morgan D., Tao Zhang, Zibo Li, et al.. (2021). High MW polyethylene glycol prolongs circulation of pegloticase in mice with anti-PEG antibodies. Journal of Controlled Release. 338. 804–812. 13 indexed citations
4.
Mallory, Raburn M., Andrew C. Nyborg, Rubana N. Kalyani, et al.. (2019). A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24–<48 months of age. Vaccine. 38(5). 1001–1008. 9 indexed citations
5.
Kroh, Heather K., Ramyavardhanee Chandrasekaran, Rob Woods, et al.. (2017). Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface. Journal of Biological Chemistry. 292(35). 14401–14412. 10 indexed citations
6.
Gruia, Flaviu, Arun Parupudi, Manuel Baca, et al.. (2017). Impact of Mutations on the Higher Order Structure and Activity of a Recombinant Uricase. Journal of Pharmaceutical Sciences. 106(4). 1018–1024. 4 indexed citations
7.
Nyborg, Andrew C., Anna Zacco, Rachel Ettinger, et al.. (2015). Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells. Cellular and Molecular Immunology. 13(3). 391–400. 45 indexed citations
8.
Chowdhury, Partha S., Yan Chen, Chunning Yang, et al.. (2012). Targeting the junction of CɛmX and ɛ-migis for the specific depletion of mIgE-expressing B cells. Molecular Immunology. 52(3-4). 279–288. 7 indexed citations
9.
Nyborg, Andrew C., Lauren Herl, Oksana Berezovska, et al.. (2006). Signal peptide peptidase (SPP) dimer formation as assessed by fluorescence lifetime imaging microscopy (FLIM) in intact cells. Molecular Neurodegeneration. 1(1). 16–16. 15 indexed citations
10.
Beher, Dirk, et al.. (2005). C‐terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation. Journal of Neurochemistry. 96(1). 218–227. 78 indexed citations
11.
Herl, Lauren, Alberto Lleó, Anne V. Thomas, et al.. (2005). Detection of presenilin-1 homodimer formation in intact cells using fluorescent lifetime imaging microscopy. Biochemical and Biophysical Research Communications. 340(2). 668–674. 23 indexed citations
12.
Nyborg, Andrew C., Anna Y. Kornilova, Karen Jansen, et al.. (2004). Signal Peptide Peptidase Forms a Homodimer That Is Labeled by an Active Site-directed γ-Secretase Inhibitor. Journal of Biological Chemistry. 279(15). 15153–15160. 71 indexed citations
13.
Nyborg, Andrew C., Karen Jansen, Thomas B. Ladd, Abdul H. Fauq, & Todd E. Golde. (2004). A Signal Peptide Peptidase (SPP) Reporter Activity Assay Based on the Cleavage of Type II Membrane Protein Substrates Provides Further Evidence for an Inverted Orientation of the SPP Active Site Relative to Presenilin. Journal of Biological Chemistry. 279(41). 43148–43156. 46 indexed citations
14.
Ramsden, M., Andrew C. Nyborg, Michael P. Murphy, et al.. (2003). Androgens modulate β‐amyloid levels in male rat brain. Journal of Neurochemistry. 87(4). 1052–1055. 111 indexed citations
15.
Wahrle, Suzanne E., Pritam Das, Andrew C. Nyborg, et al.. (2002). Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains. Neurobiology of Disease. 9(1). 11–23. 353 indexed citations
16.
17.
Johnson, Joy L., et al.. (2000). Mechanistic interpretation of the dilution effect for Azotobacter vinelandii and Clostridium pasteurianum nitrogenase catalysis. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1543(1). 36–46. 5 indexed citations
18.
Nyborg, Andrew C., et al.. (2000). Evidence for a Two-Electron Transfer Using the All-Ferrous Fe Protein during Nitrogenase Catalysis. Journal of Biological Chemistry. 275(50). 39307–39312. 23 indexed citations
19.
Nyborg, Andrew C., et al.. (2000). Reactions of Azotobacter vinelandii nitrogenase using Ti(III) as reductant. Journal of Inorganic Biochemistry. 78(4). 371–381. 9 indexed citations
20.
Schimpf, Martin E., et al.. (1997). Compositional Effects in the Retention of Colloids by Thermal Field-Flow Fractionation. Analytical Chemistry. 69(17). 3442–3450. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026